Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: February 23, 2022
Reporting Period Context: The filing announces an upcoming conference call to discuss financial results for the fourth quarter ended December 31, 2021, and provide a corporate update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of an upcoming event to discuss these metrics.
Material Changes
No material financial changes or operational updates are detailed within this specific filing. The document references a press release (Exhibit 99.1) containing the announcement but does not include the financial data itself.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will host a conference call on Thursday, March 3, 2022, at 4:30 PM Eastern Time.
- Discussion Topics: Fourth quarter 2021 results and a corporate update.
- Legal Disclaimer: The information in this report and the attached press release is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the conference call (March 3, 2022, 4:30 PM ET).
- Locate and review the attached press release (Exhibit 99.1) for any preliminary details not included in the 8-K text.
- Monitor the Company's investor relations website for the actual earnings release and transcript following the March 3 call.
- Confirm the Company's status as an emerging growth company (indicated as yes in the filing).